Sales Support
U.S.:+1-415-871-0703
U.K.:+44-203-289-4040
AUS.: +61-2-4786-0457
INDIA:+91-848-285-0837
Contact Us
We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.
Healthcare and Pharmaceuticals industry

Global Biomarkers Market Size Share Forecast 2024

  • Purchase Options

 

Impact Analysis of Covid-19

The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Biomarkers are used for diagnosis and drug development, as these biomarkers can indicate diseases in the body. Furthermore, biomarkers can be any specific cells, molecules, genes or gene products, enzymes or hormones. Biomarker-based test are precise and rapid, which help in early prediction of susceptibility, prognosis, diagnosis, and treatment of disease. Hence, increasing research and development activities for identifying new biomarkers to diagnose or treat diseases is expected to be major factor growth of the market.
Biomarker are required for personalized medicine as it helps to identify the unique characteristics of the disease and helps to tailor medicine according to the need of patients. Hence, to cater to demand for personalized medicines, pharmaceutical companies are investing in R&D, which is expected to lead to identification of novel biomarkers, thus aiding in growth of the market.
Market Dynamics
The global biomarkers market is projected to witness significant growth over the forecast period, owing to rapid advancements in technology for development of novel biomarker. For instance, in February 2018, FDA granted marketing authorization to Banyan Biomarkers, Inc. for the first diagnostic blood test for traumatic brain injury named Banyan BTI. Such innovations, targeting different indications, is expected to drive biomarkers market growth in the near future.
However, investment required for discovering a biomarker is high, due to the cumbersome biomarker validation, and testing process, which hinders growth of the biomarkers market.
Key features of the study:
• This report provides in-depth analysis of the biomarkers market size (US$ Million) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period: 2017 - 2025, considering 2016 as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by the leading players
• It profiles leading players in the global biomarkers market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies
• Key companies covered as a part of this study include Abbott Laboratories, Medtronic, BG Medicine, Inc., F. Hoffman LA Roche Ltd., Seimens Healthnineers, Nexus-DX, Qiagen N.V., and Lifesign LLC.
• Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion and marketing tactics.
• The global biomarkers market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for biomarkers market, research and consulting firms, new entrants and financial analysts.
Detailed Segmentation:
• Global Biomarkers Market, By Product Type:
o Biomarker Test Kits
o Biomarker Analyzers
• Global Biomarkers Market, By Disease Indication:
o Cancer
o Cardiovascular Disorder
o Infectious Disease
o Neurological Disorder
o Immunological Disorder
o Others
• Global Biomarkers Market, By Application:
o Diagnosis
o Drug Discovery and Development
o Others
• Global Biomarkers Market, By End User:
o Hospitals
o Research Laboratories
o Ambulatory Surgical Centers
o Diagnostic Laboratories
• Global Biomarkers Market, By Region:
o North America
 North America Biomarkers Market, By Disease Indication:
 Biomarker Test Kits
 Biomarker Analyzer
 North America Biomarkers Market, By Disease Indication:
 Cancer
 Cardiovascular Disorder
 Infectious Disease
 Neurological Disorder
 Immunological Disorder
 Others
 North America Biomarkers Market, By Application:
 Diagnosis
 Drug Discovery and Development
 Others
 North America Biomarkers Market, By End User
 Hospitals
 Research Laboratories
 Ambulatory Surgical Centers
 Diagnostic Laboratories
 North America Biomarkers Market, By Country
 U.S.
 Canada
o Europe
 Europe Biomarkers Market, By Disease Indication:
 Biomarker Test Kits
 Biomarker Analyzer
 Europe Biomarkers Market, By Disease Indication:
 Cancer
 Cardiovascular Disorder
 Infectious Disease
 Neurological Disorder
 Immunological Disorder
 Others
 Europe Biomarkers Market, By Application:
 Diagnosis
 Drug Discovery and Development
 Others
 Europe Biomarkers Market, By End User
 Hospitals
 Research Laboratories
 Ambulatory Surgical Centers
 Diagnostic Laboratories
 Europe Biomarkers Market, By Country
 U.K.
 Germany
 Italy
 France
 Spain
 Russia
 Rest of Europe
o Asia Pacific
 Asia Pacific Biomarkers Market, By Disease Indication:
 Biomarker Test Kits
 Biomarker Analyzer
 Asia Pacific Biomarkers Market, By Disease Indication:
 Cancer
 Cardiovascular Disorder
 Infectious Disease
 Neurological Disorder
 Immunological Disorder
 Others
 Asia Pacific Biomarkers Market, By Application:
 Diagnosis
 Drug Discovery and Development
 Others
 Asia Pacific Biomarkers Market, By End User
 Hospitals
 Research Laboratories
 Ambulatory Surgical Centers
 Diagnostic Laboratories
 Asia Pacific Biomarkers Market, By Country
 China
 India
 Japan
 ASEAN
 Australia
 South Korea
 Rest of Asia Pacific
o Latin America
 Latin America Biomarkers Market, By Disease Indication:
 Biomarker Test Kits
 Biomarker Analyzer
 Latin America Biomarkers Market, By Disease Indication:
 Cancer
 Cardiovascular Disorder
 Infectious Disease
 Neurological Disorder
 Immunological Disorder
 Others
 Latin America Biomarkers Market, By Application:
 Diagnosis
 Drug Discovery and Development
 Others
 Latin America Biomarkers Market, By End User
 Hospitals
 Research Laboratories
 Ambulatory Surgical Centers
 Diagnostic Laboratories
 Latin America Biomarkers Market, By Country
 Brazil
 Mexico
 Rest of Latin America
o Middle East
 Middle East Biomarkers Market, By Disease Indication:
 Biomarker Test Kits
 Biomarker Analyzer
 Middle East Biomarkers Market, By Disease Indication:
 Cancer
 Cardiovascular Disorder
 Infectious Disease
 Neurological Disorder
 Immunological Disorder
 Others
 Middle East Biomarkers Market, By Application:
 Diagnosis
 Drug Discovery and Development
 Others
 Middle East Biomarkers Market, By End User
 Hospitals
 Research Laboratories
 Ambulatory Surgical Centers
 Diagnostic Laboratories
 Middle East Biomarkers Market, By Country
 GCC
 Israel
 Rest of Middle East
o Africa
 Africa Biomarkers Market, By Disease Indication:
 Biomarker Test Kits
 Biomarker Analyzer
 Africa Biomarkers Market, By Disease Indication:
 Cancer
 Cardiovascular Disorder
 Infectious Disease
 Neurological Disorder
 Immunological Disorder
 Others
 Africa Biomarkers Market, By Application:
 Diagnosis
 Drug Discovery and Development
 Others
 Africa Biomarkers Market, By End User
 Hospitals
 Research Laboratories
 Ambulatory Surgical Centers
 Diagnostic Laboratories
 Africa Biomarkers Market, By Country
 North Africa
 Central Africa
 South Africa
• Company Profiles
o Abbott Laboratories *
 Company Overview
 Product Portfolio
 Financial Performance
 Recent Highlights
 Strategies
o Medtronic
o BG Medicine, Inc.
o Hoffman LA Roche Ltd.
o Seimens Healthnineers
o Nexus-DX
o Qiagen N.V.
o Lifesign LLC
"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents
1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Overview
o Report Description
? Market Definition and Scope
o Executive Summary
? Market Snippet, By Product Type
? Market Snippet, By Disease Indication
? Market Snippet, By Application
? Market Snippet, By End User
? Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
? Drivers
? Restraints
? Market Opportunities
o Epidemiology
o Biomarker Development Pipeline
o FDA Biomarker Qualification Program
o Qualified Biomarker By FDA
o Reimbursement Scenario
o PEST Analysis
4. Global Biomarkers Market, By Product Type, 2015-2025, (US$ Million)
o Introduction
? Market Share Analysis, 2016 and 2025 (%)
? Y-o-Y Growth Analysis, 2016-2025
? Segment Trends
o Biomarker Test Kits
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Million)
o Biomarker Analyzers
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Million)
5. Global Biomarkers Market, By Disease Indication, 2015-2025, (US$ Million)
o Introduction
? Market Share Analysis, 2016 and 2025 (%)
? Y-o-Y Growth Analysis, 2016-2025
? Segment Trends
o Cancer
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Million)
o Cardiovascular Disease
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Million)
o Infectious Disease
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Million)
o Neurological Disorder
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Million)
o Immunological Disorder
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Million)
o Others
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Million)
6. Global Biomarkers Market, By Application, 2015-2025, (US$ Million)
o Introduction
? Market Share Analysis, 2016 and 2025 (%)
? Y-o-Y Growth Analysis, 2016-2025
? Segment Trends
o Diagnosis
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Million)
o Drug Discovery and Development
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Million)
o Others
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Million)
7. Global Biomarkers Market, By End User, 2015-2025, (US$ Million)
o Introduction
? Market Share Analysis, 2016 and 2025 (%)
? Y-o-Y Growth Analysis, 2016-2025
? Segment Trends
o Hospitals
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Million)
o Research Laboratories
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Million)
o Ambulatory Surgical Centers
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Million)
o Diagnostic Laboratories
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Million)
8. Global Biomarkers Market, By Region, 2015-2025, (US$ Million)
o Introduction
? Market Share Analysis, By Region, 2016 and 2025 (%)
? Y-o-Y Growth Analysis, By Region, 2016-2025
? Regional Trends
o North America
? Market Size and Forecast, By Product Type, 2015-2025, (US$ Million)
? Market Size and Forecast, By Disease Indication, 2015-2025, (US$ Million)
? Market Size and Forecast, By Application, 2015-2025, (US$ Million)
? Market Size and Forecast, By End User, 2015-2025, (US$ Million)
? Market Size and Forecast, By Countries, 2015-2025, (US$ Million)
? U.S.
? Canada
o Europe
? Market Size and Forecast, By Product Type, 2015-2025, (US$ Million)
? Market Size and Forecast, By Disease Indication, 2015-2025, (US$ Million)
? Market Size and Forecast, By Application, 2015-2025, (US$ Million)
? Market Size and Forecast, By End User, 2015-2025, (US$ Million)
? Market Size and Forecast, By Countries, 2015-2025, (US$ Million)
? U.K.
? Germany
? Italy
? France
? Spain
? Russia
? Rest of Europe
o Latin America
? Market Size and Forecast, By Product Type, 2015-2025, (US$ Million)
? Market Size and Forecast, By Disease Indication, 2015-2025, (US$ Million)
? Market Size and Forecast, By Application, 2015-2025, (US$ Million)
? Market Size and Forecast, By End User, 2015-2025, (US$ Million)
? Market Size and Forecast, By Countries, 2015-2025, (US$ Million)
? Brazil
? Mexico
? Rest of Latin America
o Asia Pacific
? Market Size and Forecast, By Product Type, 2015-2025, (US$ Million)
? Market Size and Forecast, By Disease Indication, 2015-2025, (US$ Million)
? Market Size and Forecast, By Application, 2015-2025, (US$ Million)
? Market Size and Forecast, By End User, 2015-2025, (US$ Million)
? Market Size and Forecast, By Countries, 2015-2025, (US$ Million)
? China
? Japan
? India
? ASEAN
? Australia
? South Korea
? Rest of Asia Pacific
o Middle East
? Market Size and Forecast, By Product Type, 2015-2025, (US$ Million)
? Market Size and Forecast, By Disease Indication, 2015-2025, (US$ Million)
? Market Size and Forecast, By Application, 2015-2025, (US$ Million)
? Market Size and Forecast, By End User, 2015-2025, (US$ Million)
? Market Size and Forecast, By Countries, 2015-2025, (US$ Million)
? GCC Countries
? Israel
? Rest of Middle East
o Africa
? Market Size and Forecast, By Product Type, 2015-2025, (US$ Million)
? Market Size and Forecast, By Disease Indication, 2015-2025, (US$ Million)
? Market Size and Forecast, By Application, 2015-2025, (US$ Million)
? Market Size and Forecast, By End User, 2015-2025, (US$ Million)
? Market Size and Forecast, By Countries, 2015-2025, (US$ Million)
? North Africa
? Central Africa
? South Africa
9. Competitive Landscape
o Heat Map Analysis
o Company Profiles
? Abbott Laboratories
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Highlights
? Strategies
? Medtronic
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Highlights
? Strategies
? BG Medicine, Inc.
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Highlights
? Strategies
? F.Hoffman LA Roche Ltd.
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Highlights
? Strategies
? Seimens Healthnineers
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Highlights
? Strategies
? Nexus-DX
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Highlights
? Strategies
? Qiagen N.V.
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Highlights
? Strategies
? Lifesign LLC
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Highlights
? Strategies
o Analyst Views
10. Section
o References
o Research Methodology
o About Us and Sales Contact
*Browse 45 market data tables and 37 figures on "Biomarkers Market - Global forecast to 2025".
 

  • Purchase Options

  • Happy To Assist You

Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.

Contact us